| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
TRex Bio, Inc.
13D
TRXB · 89531N100
|
7.0% |
10/16/2026
Event 10/8/2026
|
||||
| SV Biotech Crossover Opportunities Fund LP | 7.0% | |||||
| SV Bco I GP LLP | 7.0% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.